ICU Medical, Inc. (ICUI): Price and Financial Metrics
ICU Medical, Inc. (ICUI)
Today's Latest Price: $188.97 USD
Updated Dec 1 6:55pm
Add ICUI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
ICUI Stock Summary
- For ICUI, its debt to operating expenses ratio is greater than that reported by just 0.51% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Icu Medical Inc's debt growth rate surpasses only 0% of about US stocks.
- In terms of volatility of its share price, ICUI is more volatile than just 2.3% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Icu Medical Inc, a group of peers worth examining would be GMED, TRUE, SPSC, SSTK, and PLPC.
- ICUI's SEC filings can be seen here. And to visit Icu Medical Inc's official web site, go to www.icumed.com.
ICUI Stock Price Chart Interactive Chart >
ICUI Price/Volume Stats
| Current price | $188.97 | 52-week high | $236.51 |
| Prev. close | $188.70 | 52-week low | $158.01 |
| Day low | $188.00 | Volume | 105,800 |
| Day high | $191.02 | Avg. volume | 152,239 |
| 50-day MA | $188.69 | Dividend yield | N/A |
| 200-day MA | $192.10 | Market Cap | 3.96B |
ICU Medical, Inc. (ICUI) Company Bio
ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.
ICUI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $188.97 | $71.58 | -61% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Icu Medical Inc. To summarize, we found that Icu Medical Inc ranked in the 26th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for ICUI, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Its equity weight surpasses that of 95.79% of free cash flow generating stocks in the Healthcare sector.
- The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than merely 0.05% of the free cash flow producing stocks we're observing.
- ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 55.86% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -62% |
| 1% | -62% |
| 2% | -61% |
| 3% | -61% |
| 4% | -61% |
| 5% | -60% |
ENTA, WAT, ILMN, XRAY, and A can be thought of as valuation peers to ICUI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...